Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ricardo Guadalupe Salazar LealfiledCriticalRicardo Guadalupe Salazar Leal
Priority to MX2008001011ApriorityCriticalpatent/MX2008001011A/en
Publication of MX2008001011ApublicationCriticalpatent/MX2008001011A/en
The present invention refers to an adjuvant product in the treatment for controlling blood glucose levels, which main characteristics are that it is made of food-grade ingredients so that it may be used by any person requiring it and even by those that do not require it without producing side effects; the product does not require a medical prescription since it is not a drug but a natural supplement, which due to the aforementioned properties, is able to make a positive change in the organism in order to control the disease; in addition, it does not have short-, medium- or long-term side effects according to the studies carried out and attached to the file. The purpose of the present invention is to provide a natural formulation (food supplement) to people requiring a blood glucose level control with the aforesaid characteristics, which may offer an improved life level and quality by means of the disease control.
MX2008001011A2008-01-222008-01-22Adjuvant formulation for controlling high levels of glucose in blood (hyperglycaemia).
MX2008001011A
(en)
Selective Effect s of Individual Antipsychotic Cotreatments on Cardiometabolic and Hormonal Risk Status: Results from a Systematic Review and Meta-analysis